Aerovate Therapeutics, Inc. (AVTE)

NASDAQ: AVTE · IEX Real-Time Price · USD
13.16
0.39 (3.05%)
May 20, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Selling, General & Admin
8.040.950.22
Research & Development
14.997.943.11
Operating Expenses
23.028.893.33
Operating Income
-23.02-8.89-3.33
Interest Expense / Income
-0.070.080
Other Expense / Income
00.65-0
Pretax Income
-22.96-9.61-3.33
Income Tax
000
Net Income
-22.96-9.61-3.33
Net Income Common
-22.96-9.61-3.33
Shares Outstanding (Basic)
1201
Shares Outstanding (Diluted)
1201
Shares Change
4975.15%-67.70%-
EPS (Basic)
-1.87-40.31-4.44
EPS (Diluted)
-1.87-40.31-4.44
Free Cash Flow Per Share
-2.24-32.44-3.71
Effective Tax Rate
-0.01%0.00%-0.03%
EBITDA
-23.01-9.54-3.33
EBIT
-23.03-9.54-3.33
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).